CN1218735C - Medicine composition for treating pain in waist and lower limbs and hyperosteogeny - Google Patents
Medicine composition for treating pain in waist and lower limbs and hyperosteogeny Download PDFInfo
- Publication number
- CN1218735C CN1218735C CN 03130831 CN03130831A CN1218735C CN 1218735 C CN1218735 C CN 1218735C CN 03130831 CN03130831 CN 03130831 CN 03130831 A CN03130831 A CN 03130831A CN 1218735 C CN1218735 C CN 1218735C
- Authority
- CN
- China
- Prior art keywords
- weight portion
- hyperosteogeny
- radix
- treatment
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a medicinal composition for treating lumbar and leg pain, and hyperosteogeny, which is prepared from crude drugs such as astragalus, psoralea fruit, red sage root, paniculate swallowwort root, Wenyujin concise rhizome, tripterygium wilfordii, dahurian angelica, asarum, rhizoma corydalis, Chinese ephedra and tiger's fat. The medicinal composition of the present invention has significant effect on the treatment of lumbar and leg pain, and hyperosteogeny with no toxic or side effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of lumbago and skelalgia, hyperosteogeny.
Background technology
Lumbago and skelalgia is that a kind of serious harm people healthy commonly encountered diseases, frequently-occurring disease, lumbar intervertebral disc go out that disease is that nerve root is hemorrhage because the prolapse of lumbar intervertebral disc that causes of a variety of causes causes the intraspinal pressure height, edema, inflammation, pain etc., and this patient's pain unbearably; The method that social at present upward treatment lumbar intervertebral disc goes out disease is roughly operative therapy, this therapy is very big to the damage of human body, because in the treatment prolapse of lumbar intervertebral disc of having an operation, lumbar intervertebral disc protrusion be must bump, wipe even hurt and periphery other normal tissue system and cell become, the function of other each organ of health also sustains damage and bad influence, destroy the immunologic function of human body, caused whole health to be difficult to recover Primordial Qi.
Hyperosteogeny is the aged a kind of performance of skeleton, also is one of common frequently-occurring disease of old people.Present domestic medical circle treatment hyperosteogeny main method has: traction, massage, surgical operation etc., and these Therapeutic Method cause very big misery to the patient, and the treatment condition has certain limitation, dangerous big, the course of treatment is long, and human body is had damage, weak effect, cure rate is low, easily recurrence.
Technology contents
The object of the present invention is to provide a kind of pharmaceutical composition for the treatment of lumbago and skelalgia, hyperosteogeny.
The object of the present invention is achieved like this: choose crude drug
Radix Astragali 500-150 weight portion Fructus Psoraleae 500-1500 weight portion
Radix Salviae Miltiorrhizae 500-1500 weight portion Radix Cynanchi Paniculati 500-1500 weight portion
Rhizoma Wenyujin Concisum 500-1500 weight portion Radix Tripterygii Wilfordii 200-1000 weight portion
Radix Angelicae Dahuricae 200-1000 weight portion Herba Asari 50-250 weight portion
Rhizoma Corydalis 200-1000 weight portion Herba Ephedrae 30-150 weight portion
Herba Siegesbeckiae 100-500 weight portion
Optimum ratio of the present invention is: choose crude drug
The Radix Astragali 1000 weight portion Fructus Psoraleaes 1000 weight portion Radix Salviae Miltiorrhizaes 1000 weight portions
Radix Cynanchi Paniculati 1000 weight portion Rhizoma Wenyujin Concisum 1000 weight portion Radix Tripterygii Wilfordiis 500 weight portions
The Radix Angelicae Dahuricae 500 weight portion Herba Asaris 150 weight portion Rhizoma Corydalis 500 weight portions
Herba Ephedrae 100 Chong Liang Fen Herba Siegesbeckiaes 300 weight portions
Said medicine adds cold water 10000 weight portions soaked after 6 hours, and intense fire is fried boiling and changes 90 minutes at a simmer, and filtration takes concoction, and adds crystal sugar 500 weight portions while hot, and treating ℃ to add 50 ° of Chinese distillate spirits 2000 weight portions again by medicine temperature drop to 30, to mix well bottling standby.
Pharmaceutical composition of the present invention also can be made into acceptable tablet, pill, capsule, granule, electuary, oral liquid clinically.
Pharmaceutical composition of the present invention is evident in efficacy to treatment prolapse of lumbar intervertebral disc, sciatica, osteoproliferation arthritis (cervical vertebra, lumbar vertebra, knee osteoarthritis), wind (class) wet arthritis, scapulohumeral periarthritis, trigeminal neuralgia etc., and has no side effect.
One, clinical data
Medicine composite for curing prolapse of lumbar intervertebral disc of the present invention and hyperosteogeny 180 examples, wherein male 112 examples, women 68 examples, the course of disease 3 months-15 years, prolapse of lumbar intervertebral disc 122 examples, osteoproliferation arthritis 58 examples.Make a definite diagnosis all according to diagnostic imaging in conjunction with clinical symptoms.
Two, Therapeutic Method
Lumbar intervertebral disc and hyperosteogeny are taken the each 30ml-50ml of the present invention's (YAOTONGNING) medicated wine, and three times on the one, 3-7 days is produce effects.30 days is a course of treatment.
Three, criterion of therapeutical effect
1, lumbar vertebral disc disease: 1. cure, pain disappears, and activity freely.
2. produce effects, disease disappears, and gets involved, and slightly repeatedly, waist lower limb fiber crops are expanded and increase the weight of.
2, hyperosteogeny: 1. cure clinical symptom disappearance, not recurrence after half a year.
2. produce effects, symptom disappears substantially, but has got involved gently repeatedly.
3. effective, though sx, medication 3-5 course of treatment, produce effects is little.
Four, result: the present invention's (YAOTONGNING) medicated wine curative effect table
| Name of disease | Drug treatment | |||||||||||
| One | Two | Three | ||||||||||
| Lumbar spondylosis | Total routine number | Cure | Produce effects | Effectively | Cure | Produce effects | Effectively | Cure | Produce effects | Effectively | Total cure (%) | Total effectively (%) |
| 122 | 56 | 66 | 53 | 12 | 1 | 99.2％ | 100％ | |||||
| Hyperosteogeny | 58 | 36 | 22 | 22 | 8 | 8 | 34 | 2 | 96.5％ | 100％ | ||
Five, model case:
Woman Liu, 75 years old, Mouping District Jiu Longkuang people from village, prolapse of lumbar intervertebral disc 3 months is in treatments such as local hospital row sacrum duct occlusion, not produce effects.Take three days pains of this medicine and alleviate, life can be taken care of oneself, one the course of treatment pain disappear entirely, recur again more than a year.
Reed suffers from scapulohumeral periarthritis half a year, and the multi-treatment state of an illness is shown effect repeatedly through whole bone hospital of local hospital and Wendeng City, takes this medicine half course of treatment of wine and heal, recurs in this year.
Six, sum up: pharmacodynamic analysis
The Radix Astragali, Fructus Psoraleae are tonified Qi of the kidney, and consolidate the merit of yang invigorating, are monarch.
Sheet Rhizoma Zingiberis Recens, Radix Salviae Miltiorrhizae have the merit of vegetables ruton warp, activating blood circulation to dissipate blood stasis, are minister.
Radix Cynanchi Paniculati, rare grass of Radix Tripterygii Wilfordii have expelling wind and dampness, detumescence to lose the merit of pain, are assistant.
Make.Because compatibility is reasonable, so obtained promising result clinically.
Usage: each 30-50ml, three times on the one, taking medicine before meal usefulness, boiled water takes.
Embodiment 1
Choose crude drug:
Radix Astragali 1000g Fructus Psoraleae 1000g Radix Salviae Miltiorrhizae 1000g Radix Cynanchi Paniculati 1000g
Rhizoma Wenyujin Concisum 1000g Radix Tripterygii Wilfordii 500g Radix Angelicae Dahuricae 500g Herba Asari 150g
Rhizoma Corydalis 500g Herba Ephedrae 100g Herba Siegesbeckiae 300g
Said medicine adds cold water 10000ml soaked after 6 hours, and intense fire is fried boiling and changes 90 minutes at a simmer, filters the 7000ml that takes concoction, and adds crystal sugar 500g while hot, and treating ℃ to add 50 ° of Chinese distillate spirits 2000ml again by medicine temperature drop to 30, to mix well bottling standby.Be 100 days consumptions altogether; Each 30-50ml, three times on the one, taking medicine before meal usefulness, boiled water takes.
Embodiment 2
Choose crude drug:
Radix Astragali 1000g Fructus Psoraleae 1000g Radix Salviae Miltiorrhizae 1000g Radix Cynanchi Paniculati 1000g
Rhizoma Wenyujin Concisum 1000g Radix Tripterygii Wilfordii 500g Radix Angelicae Dahuricae 500g Herba Asari 150g
Rhizoma Corydalis 500g Herba Ephedrae 100g Herba Siegesbeckiae 300g
Said medicine technology routinely is ground into fine powder, incapsulates.
Claims (2)
1, a kind of pharmaceutical composition for the treatment of lumbago and skelalgia, hyperosteogeny is characterized in that said composition is to be made by following crude drug:
The Radix Astragali 1000 weight portion Fructus Psoraleaes 1000 weight portion Radix Salviae Miltiorrhizaes 1000 weight portions
Radix Cynanchi Paniculati 1000 weight portion Rhizoma Wenyujin Concisum 1000 weight portion Radix Tripterygii Wilfordiis 500 weight portions
The Radix Angelicae Dahuricae 500 weight portion Herba Asaris 150 weight portion Rhizoma Corydalis 500 weight portions
Herba Ephedrae 100 Chong Liang Fen Herba Siegesbeckiaes 300 weight portions.
2, pharmaceutical composition as claimed in claim 1 is characterized in that said composition makes tablet, pill, capsule, granule, electuary or oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03130831 CN1218735C (en) | 2003-05-08 | 2003-05-08 | Medicine composition for treating pain in waist and lower limbs and hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03130831 CN1218735C (en) | 2003-05-08 | 2003-05-08 | Medicine composition for treating pain in waist and lower limbs and hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1490034A CN1490034A (en) | 2004-04-21 |
| CN1218735C true CN1218735C (en) | 2005-09-14 |
Family
ID=34153792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03130831 Expired - Fee Related CN1218735C (en) | 2003-05-08 | 2003-05-08 | Medicine composition for treating pain in waist and lower limbs and hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1218735C (en) |
-
2003
- 2003-05-08 CN CN 03130831 patent/CN1218735C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1490034A (en) | 2004-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1895549A (en) | Soothe tendons and activating-blood anodyne plaster | |
| CN101129973A (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
| CN1876084A (en) | Ointment for orthopedics | |
| CN101537060A (en) | Medicine for treating AIDS | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN102343008B (en) | Chinese medicinal composition for treating prolapse of lumbar intervertebral disc | |
| CN101279080B (en) | Medicament composition for curing cervical vertebra disease, lumbar disease and traumatic injury and preparation method | |
| CN1218735C (en) | Medicine composition for treating pain in waist and lower limbs and hyperosteogeny | |
| CN1112206C (en) | Bone fracture setting medicine powder | |
| CN1895593A (en) | Medicine for treating acne and its preparation | |
| CN107320698A (en) | A kind of Chinese medicine compound prescription for treating person in middle and old age's nerve root cervical vertebra sickness and its application | |
| CN102430096B (en) | Medicament for treating rheumatic or rheumatoid diseases | |
| CN105012612A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN101485800A (en) | Medicament composition for treating pain in waist and leg | |
| CN104606313A (en) | Traditional Chinese medicinal ointment for treating osteoarticular diseases and bone fractures | |
| CN104547591A (en) | Pharmaceutical composition for treating acute ankle sprain | |
| CN1297305C (en) | Chinese medicinal composition for warming and transforming stasis, dispersing swell and engendering bone | |
| CN101744901B (en) | Medicinal pillow for treating cervical spondylosis | |
| CN102441148A (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
| CN100536895C (en) | Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny | |
| CN1305510C (en) | Medicine for treating intractable fever | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN100371006C (en) | Chinese traditional medicine formula for curing cysticercosis | |
| CN1284576C (en) | External-use Chinese medicine for treating osteoproliferation and its preparing method | |
| CN1623588A (en) | Chinese medicinal composition for treating bone fracture and soft tissue injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050914 |